Welcome to our dedicated page for Osi Systems SEC filings (Ticker: OSIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading OSI Systems’ filings can feel like navigating airport security itself—hundreds of pages on Rapiscan scanners, patient monitors, and optoelectronic sensors, all wrapped in export-control fine print. If you are searching for “OSI Systems SEC filings explained simply”, you have arrived at the right gate.
Stock Titan applies AI that highlights the exact paragraph where a new TSA contract, FDA clearance, or risk factor first appears. Whether you need an “OSI Systems quarterly earnings report 10-Q filing” to compare segment margins, or an “OSI Systems annual report 10-K simplified” to grasp multi-year backlog trends, our platform delivers concise, plain-English summaries alongside the original document.
Key insights you can unlock immediately:
- Real-time OSI Systems Form 4 insider transactions with alerts on executive stock moves—ideal for tracking potential confidence signals.
- Instant context for an OSI Systems 8-K material events explained notice, such as large airport-security orders or product recalls.
- Deep dives into the OSI Systems proxy statement executive compensation to see how bonuses align with segment performance.
Each filing type answers different investor questions. The 10-Q details supply-chain cost shifts between Security and Healthcare, while Form 4 data pinpoints OSI Systems insider trading Form 4 transactions around contract announcements. Our AI pairs these documents with clear charts, saving hours of manual review and offering the OSI Systems earnings report filing analysis you need to act decisively.
Stop scrolling through EDGAR tables. Start understanding OSI Systems SEC documents with AI—updated the moment they hit the wire.
Alan Edrick, EVP & CFO of OSI Systems (OSIS), reported changes in his beneficial ownership on Form 4. On 08/26/2025 he was granted 28,345 RSUs issued pursuant to performance-based vesting at an indicated price of $225.19 per share equivalent, bringing his total common shares to 321,958 (direct). On the same date a separate transaction coded "F" shows 25,078 shares tendered in a net settlement to cover tax withholding at $225.19, reducing his post-transaction direct holdings to 296,880 shares. The filing clarifies the RSUs are performance-based and no shares were sold in the net settlement.
Deepak Chopra, Executive Chairman of OSI Systems, reported Form 4 transactions dated 08/26/2025. The filing shows the grant of 82,845 restricted stock units issued pursuant to performance-based vesting and recorded at a price of $225.19, which increased reported beneficial ownership to 414,600 shares. The filing also shows a net settlement disposition of 77,131 shares to satisfy tax withholding obligations (no shares sold), leaving 337,469 shares beneficially owned following the reported transactions. The form is signed by Mr. Chopra on 08/28/2025.
Ajay Mehra, President and CEO of OSI Systems (OSIS), reported transactions on 08/26/2025. He was issued 15,362 performance-based restricted stock units (RSUs) and, pursuant to a net settlement to cover withholding taxes, 18,850 shares were tendered (disposed). After the transactions Mr. Mehra beneficially owned 98,107 shares directly and 6,683 shares indirectly through the Mehra Family Trust, for a combined total shown on the form. The reported per-share price for the transactions was $225.19. The RSUs are described as performance-based and the Mehra Family Trust is dated 7-12-2008.
OSI Systems insider Cary M. Okawa reported a non‑derivative disposition of 84 shares of common stock on 08/22/2025. The filing shows the shares were tendered to satisfy tax withholding obligations under a net settlement and no shares were sold on the open market. After the withholding, Mr. Okawa beneficially owned 2,990 shares held directly. The report was signed on 08/25/2025 and lists his role as Chief Accounting Officer and director.
OSI Systems, Inc. presents an annual 10-K with several operational, regulatory, and financial disclosures. Management concluded internal control over financial reporting was effective as of June 30, 2025. The company maintains annual third-party cybersecurity audits and an ISO/IEC 27001 certification process. EU Medical Device Regulation changes broaden device scope and require expanded clinical evaluation and a designated compliance officer. Capital structure notes include 16,825,913 shares outstanding as of August 18, 2025 and a 2.25% convertible senior note due 2029 with a conversion price of $191.98. Concentration risk exists in the Security division receivables (one customer ~42% at June 30, 2025). The company disclosed a Department of Justice subpoena related to a former employee and reported transaction gains/(losses) of approximately $2.0M, ($5.1M), and ($12.7M) for fiscal 2023–2025. Other notable items: performance bond exposure of ~$104M, unrecognized tax benefits of $15.1M, and $12.7M of restricted stock unit compensation to be recognized over ~2.2 years.
Meyer Luskin, a director of OSI Systems Inc. (OSIS), reported a purchase of 470 shares of the issuer's common stock on 08/20/2025 at a price of $223.39 per share. After the reported acquisition, the filing shows 11,684 shares beneficially owned indirectly through the Meyer and Doreen Luskin Family Trust with Meyer and Doreen Luskin as trustees. The Form 4 also lists a disposition of 4,587 shares but does not provide a transaction date, price, or additional detail for that disposition within the visible tables. The filing is signed by Meyer Luskin on 08/22/2025.
Deepak Chopra, Executive Chairman and Director of OSI Systems, reported an insider purchase of common stock on 08/20/2025. He acquired 1,052 shares at a price of $223.39 per share, increasing his beneficial ownership to 331,755 shares. The Form 4 was signed on 08/22/2025 and identifies Chopra as the sole reporting person for this transaction.
William F. Ballhaus Jr., a director of OSI Systems, reported changes in his beneficial ownership on Form 4. On 08/20/2025 he purchased 1,007 shares of OSIS common stock at $223.39 per share and, following the transaction, beneficially owned 26,162 shares indirectly through the Ballhaus Trust. The filing also reports a disposition of 3,701 shares (reported on the same table). The Ballhaus Trust is identified as U/A 1/25/02 with William Ballhaus Jr. and Jane K. Ballhaus as trustees. The Form 4 was signed on 08/22/2025.
William F. Ballhaus Jr., a director of OSI Systems, Inc. (OSIS), reported insider transactions on Form 4 covering activity dated 08/20/2025. The filing shows an acquisition of 1,007 shares of OSIS common stock at a price of $223.39 per share, and a contemporaneous disposition of 3,701 shares. After the reported acquisition, the filing discloses beneficial ownership of 26,162 shares held indirectly through the Ballhaus Trust U/A 1/25/02, for which Dr. William Ballhaus Jr. and Jane K. Ballhaus are trustees. The Form 4 is signed by Mr. Ballhaus on 08/22/2025.
William Francis Ballhaus Jr., a director of OSI Systems, purchased 1,007 shares of OSIS common stock on 08/20/2025 at a reported price of $223.39 per share under transaction code A (acquisition). After the transaction, the filing shows beneficial ownership of 26,162 shares held indirectly through the Ballhaus Trust U/A 1/25/02 (with Dr. William Ballhaus Jr. and Jane K. Ballhaus as trustees). The filing also reports a separate disposition of 3,701 shares (no price shown). The Form 4 was signed by Mr. Ballhaus on 08/22/2025 and lists his relationship as a director.
FAQ
What is the current stock price of Osi Systems (OSIS)?
What is the market cap of Osi Systems (OSIS)?
